Study of microfluidic cell chip for the toxicity test of artemisinin on Hep-G2 cells

Abstract

A novel microfluidic chip composed of a 6 × 6 array of cell culture microchambers was designed and fabricated in this article. The microchip analytical system combined with the designed microchip, measuring device and environmental control unit was established for cell culture and parallel drug cytotoxicity assay. Human hepatoma cell Hep-G2 and artemisinin were taken as the objective samples in the experiments. Hep-G2 cells were successfully cultured in the microchip for over 72 h. Moreover, the viability percentage of the Hep-G2 cells was higher than 90% with staining of trypan blue. The Hep-G2 cells were exposed to the artemisinin solutions at different concentrations (0, 10, 25, 50, 100 and 150 µmol L⁻¹) for 12, 24 and 48 h. The viability of the Hep-G2 cells in chambers was measured by observing cellular morphology and detecting fluorescence intensity. Results showed that artemisinin could inhibit the viability of Hep-G2 cells, which depended on the dose of artemisinin and action time. The microchip analytical system could not only solve the shortcomings of conventional in vitro cell culture, such as labor intensive, reagent consuming and time consuming, but also improve great potential for the study of cell biology in the directions of miniaturization, automation, high efficiency and high sensitivity.

Keywords

Microfluidic cell chip human hepatoma cell Hep-G2 artemisinin cell toxicity test

Get full access to this article

View all access options for this article.

References

Croston

GE.

Functional cell-based uHTS in chemical genomic drug discovery. Trends Biotechnol 2002; 20: 110–115.

Annalisa

Mauro

Federico

. A microfluidic gradient maker for toxicity testing of bupivacaine and lidocaine. Toxicol in Vitro 2008; 22: 1957–1964.

Paguirigan

Beebe

DJ.

From the cellular perspective: exploring differences in the cellular baseline in macroscale and microfluidic cultures. Integr Biol (Camb) 2009; 1: 182–195.

Kloss

Kurz

Jahnke

. Microcavity array (MCA)-based biosensor chip for functional drug screening of 3D tissue models. Biosens Bioelectron 2008; 23: 1473–1480.

Huang

Cui

ZF.

A high throughput perfusion-based microbioreactor platform integrated with pneumatic micropumps for three-dimensional cell culture. Biomed Microdevices 2008; 10: 309–319.

Koh

Pishko

MV.

Fabrication of cell-containing hydrogel microstructures inside microfluidic devices that can be used as cell-based biosensors. Anal Bioanal Chem 2006; 385: 1389–1397.

Sung

Shuler

ML.

A micro cell culture analog (mCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs. Lab Chip 2009; 10: 1385–1394.

Zhang

Kim

Thorsen

. A self-contained microfluidic cell culture system. Biomed Microdevices 2009; 11: 1233–1237.

Wang

Kim

Marquez

. High-density microfluidic arrays for cell cytotoxicity analysis. Lab Chip 2007; 7: 740–745.

10.

Posner

Northrop

Paik

. New chemical and biological aspects of artemisinin-derived trioxane dimers. Bioorg Med Chem 2002; 10: 227–232.

11.

Thomas

Olbrich

Bauer

mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether. Biochem Pharmacol 2002; 64: 617–623.

12.

Chen

Zhou

Fang

Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro. Pharmacol Res 2003; 48: 231–236.